IndraLab

Statements


SCN9A activates NAV1. 1 / 1
| 1

reach
"These preliminary findings reported herein, when combined with the previously reported efficacy of the active ingredient of TV-45070 in IEM patients where the mutations in the SCN9A gene are known to cause a gain-of-function of Nav1.7 channel, support the continued evaluation of the R1150W polymorphism in larger clinical studies in common disorders of pain."